PALO ALTO, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO - News), a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative disorders, announced to...